Yuyu Pharma, Inc. (KRX:000220)
South Korea · Delayed Price · Currency is KRW 3,615.00
-25.00 (-0.69%)
Last updated: Jul 22, 2026, 2:01 PM KST
Yuyu Pharma Market Cap
Yuyu Pharma has a market cap or net worth of 56.69 billion as of July 22, 2026. Its market cap has decreased by -24.50% in one year.
Market Cap
56.69B
Enterprise Value
67.13B
Revenue
143.52B
Ranking
n/a
PE Ratio
6.71
Stock Price
3,615.00
ChartMarket Cap Chart
Since August 31, 1995, Yuyu Pharma's market cap has increased from 11.10B to 56.69B, an increase of 410.57%. That is a compound annual growth rate of 5.42%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 22, 2026 | 56.69B | -20.27% |
| Dec 30, 2025 | 71.10B | -2.47% |
| Dec 30, 2024 | 72.90B | -14.68% |
| Dec 28, 2023 | 85.44B | -16.84% |
| Dec 29, 2022 | 102.75B | -21.01% |
| Dec 30, 2021 | 130.08B | 20.22% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| HLB Pharmaceutical | 121.75B |
| Kyongbo Pharmaceutical | 119.30B |
| CMG Pharmaceutical | 118.35B |
| AptaBio Therapeutics | 116.45B |
| HANDOK | 106.92B |
| Jeil Pharma Holdings | 100.55B |
| Enzychem Lifesciences | 76.86B |
| CKD Bio | 70.49B |